CANADIAN ZINC CORP | CIK:0000910569 | 3

  • Filed: 3/29/2018
  • Entity registrant name: CANADIAN ZINC CORP (CIK: 0000910569)
  • Generator: DataTracks
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/910569/000127956918000610/0001279569-18-000610-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/910569/000127956918000610/czicf-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0000910569
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory

    12.
    Reserves
     
    (a)
    Stock Options
     
    The Company’s stock option plan is a fixed share stock option plan pursuant to which options on up to 7,500,000 common shares may be issued to directors, officers, employees and service providers of the Company. Each option granted shall be for a term not exceeding five years from the date of grant and the vesting period is determined at the discretion of the Board. The option exercise price is set at the date of grant and cannot be less than the closing market price of the Company’s common shares on the TSX on the day of grant. At December 31, 2017, there were 5,200,000 incentive stock options outstanding. Each stock option is exercisable for one ordinary share of the Company. No amounts are paid or payable by the recipient on receipt of the option. The options carry neither rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting to the date of their expiry.
     
     
     
    December 31, 2017
     
    December 31, 2016
     
     
     
    Number of
    Options
     
    Weighted
    Average
    Exercise
    Price
     
    Number of
    Options
     
    Weighted
    Average
    Exercise
    Price
     
    Outstanding, beginning of year
     
     
    5,850,000
     
    $
    0.36
     
     
    973,800
     
    $
    0.55
     
    Expired
     
     
    (650,000)
     
     
    0.46
     
     
    (323,800)
     
     
    0.72
     
    Granted
     
     
    -
     
     
    -
     
     
    5,200,000
     
     
    0.35
     
    Outstanding, end of year
     
     
    5,200,000
     
    $
    0.35
     
     
    5,850,000
     
    $
    0.36
     
     
    As at December 31, 2017, the Company had outstanding and exercisable stock options, with a weighted average remaining contractual life of 3.6 years, to purchase an aggregate 5,200,000 common shares as follows:
     
     
     
    Options Outstanding
     
    Options Exercisable
     
    Expiry Date
     
     
     
     
     
    Number of
    Options
     
    Weighted Average
    Exercise Price
     
    August 10, 2021
     
     
    5,200,000
     
    $
    0.35
     
     
    3,900,000
     
    $
    0.35
     
     
     
     
    5,200,000
     
    $
    0.35
     
     
    3,900,000
     
    $
    0.35
     
     
    For the year ended December 31, 2017, the Company recorded share-based compensation expense for stock options granted to directors, officers and employees of $361,000 (2016 - $492,000 and 2015 - $nil).
     
    The share-based compensation expense was determined using the Black-Scholes option pricing model, based on the following terms and assumptions:
     
    Year of Grant
     
    Year ended December 31, 2016
     
    Dividend Yield
     
     
    0%
     
    Risk free interest rate
     
     
    0.54%
     
    Expected life
     
     
    2.6 to 3.5 years
     
    Expected volatility (1)
     
     
    92% to 97%
     
    Weighted average grant date fair value of the options granted
     
     
    $0.19
     
     
    (1) Determined based on historical volatility of the Company’s share price.
     
    (b)
    Restricted Share Units (“RSUs”) and Deferred Share Units (“DSUs”)
     
    At the Annual General Meeting held on June 19, 2014, shareholders approved the adoption of a Restricted Share Unit Plan (the “RSU Plan”) and a Deferred Share Unit Plan (the “DSU Plan”). The RSU Plan and the DSU Plan provide for the issuance of shares to eligible employees, directors and consultants, subject to certain vesting and deferral provisions, to a maximum number, equal to 3% and 2% respectively, of the issued and outstanding common shares of the Company.
     
    During the year ended December 31, 2017, the Company issued 662,440 DSUs to directors and did not issue RSUs to senior officers (December 31, 2016 – 376,034 DSUs and 1,900,000 RSUs).
     
    At December 31, 2017, there were 1,123,844 DSUs and 5,550,000 RSUs outstanding (December 31, 2016 – 461,404 DSUs and 5,550,000 RSUs).
     
     
     
    Number of
    DSUs
     
    Weighted average
    grant date fair value
     
    Number of
    RSUs
     
    Weighted average
    grant date fair value
     
    Outstanding, December 31, 2015
     
     
    276,340
     
    $
    0.09
     
     
    3,650,000
     
    $
    0.11
     
    Redeemed
     
     
    (190,970)
     
     
    0.13
     
     
    -
     
     
    -
     
    Granted
     
     
    376,034
     
     
    0.24
     
     
    1,900,000
     
     
    0.33
     
    Outstanding, December 31, 2016
     
     
    461,404
     
     
    0.20
     
     
    5,550,000
     
     
    0.19
     
    Granted
     
     
    662,440
     
     
    0.19
     
     
    -
     
     
    -
     
    Outstanding, December 31, 2017
     
     
    1,123,844
     
    $
    0.19
     
     
    5,550,000
     
    $
    0.19
     
     
    The RSUs granted were subject to a ten to eighteen month vesting period; a pay-out date of 2.5 to 3 years; an expiry date of 5 years; and are assigned a fair value based on the share price at time of issuance. Upon issuance, the DSUs are fully vested and are assigned a fair value based on the share price at time of issuance. Subject to the terms and conditions of the DSU Plan, DSUs are settled upon retirement.
     
    For the year ended December 31, 2017, the Company recognized share-based compensation expense for DSUs granted of $125,000 (2016 - $90,000 and 2015 - $25,000) and RSUs granted of $356,000 (2016 - $522,000 and 2015 - $99,000).
     
    Subsequent to year-end, on January 24, 2018, the Company issued 2,300,000 RSUs to senior management with a vesting date of December 31, 2018, a pay-out date of January 1, 2020 and an expiry date of December 31, 2022.
     
    (c)
    Share Purchase Warrants
     
    As at December 31, 2017, the Company has outstanding exercisable warrants to purchase an aggregate 2,448,000 common shares, with a remaining contractual life of 6 months, as follows:
     
     
     
    December 31, 2017
     
    December 31, 2016
     
     
     
    Number of
    Warrants
     
    Weighted
    Average
    Exercise
    Price
     
    Number of
    Warrants
     
    Weighted
    Average
    Exercise
    Price
     
    Outstanding, beginning of year
     
     
    16,734,000
     
    $
    0.46
     
     
    16,908,360
     
    $
    0.48
     
    Exercised
     
     
    -
     
     
    -
     
     
    (406,200)
     
     
    0.35
     
    Expired
     
     
    (14,286,000)
     
     
    0.50
     
     
    (2,216,160)
     
     
    0.35
     
    Issued
     
     
    -
     
     
    -
     
     
    2,448,000
     
     
    0.25
     
    Outstanding, end of period
     
     
    2,448,000
     
    $
    0.25
     
     
    16,734,000
     
    $
    0.46
     
     
     
     
    Warrants Outstanding and Exercisable
     
    Expiry Date
     
    Number of Warrants
     
    Weighted Average Exercise Price
     
    July 7, 2018
     
     
    2448000
     
     
    0.25
     
     
     
    $
    2,448,000
     
    $
    0.25
     
     
    The fair value ($440,000 – see Note 11) of warrants, issued during the year ended December 31, 2016, was determined using the Black-Scholes option pricing model, based on the following terms and assumptions:
     
    Year of Grant
     
    Year ended December 31, 2016
     
    Dividend Yield
     
     
    0
    %
    Risk free interest rate
     
     
    0.47
    %
    Expected life
     
     
    2 years
     
    Expected volatility (1)
     
     
    109
    %
    Weighted average grant date fair value of the warrants issued
     
     
    $0.18
     
     
    (1) Determined based on historical volatility of the Company’s share price.
     
    (d)
    Summary
     
    A summary of the changes to the reserves is summarized below as follows:
     
     
     
    Share Options
    and Units
     
    Warrants
     
    Unexercised
    Share Options,
    Units and
    Warrants
     
    Normal
    Course
    Issuer Bid
     
    Total
     
    Balance, December 31, 2015
     
    $
    234
     
    $
    1,722
     
    $
    11,834
     
    $
    604
     
    $
    14,394
     
    Deferred share units exercised
     
     
    (24)
     
     
    -
     
     
    -
     
     
    -
     
     
    (24)
     
    Share-based compensation
     
     
    1,104
     
     
    -
     
     
    -
     
     
    -
     
     
    1,104
     
    Stock options expired
     
     
    (114)
     
     
    -
     
     
    114
     
     
    -
     
     
    -
     
    Warrants exercised
     
     
    -
     
     
    (41)
     
     
    -
     
     
    -
     
     
    (41)
     
    Warrants expired
     
     
    -
     
     
    (226)
     
     
    226
     
     
    -
     
     
    -
     
    Warrants issued
     
     
    -
     
     
    440
     
     
    -
     
     
    -
     
     
    440
     
    Balance, December 31, 2016
     
     
    1,200
     
     
    1,895
     
     
    12,174
     
     
    604
     
     
    15,873
     
    Share-based compensation
     
     
    842
     
     
    -
     
     
    -
     
     
    -
     
     
    842
     
    Stock options expired
     
     
    (143)
     
     
    -
     
     
    143
     
     
    -
     
     
    -
     
    Warrants expired
     
     
    -
     
     
    (1,456)
     
     
    1,456
     
     
    -
     
     
    -
     
    Balance, December 31, 2017
     
    $
    1,899
     
    $
    439
     
    $
    13,773
     
    $
    604
     
    $
    16,715